Ann Winter-Vann

Ann Winter-Vann has a diverse work experience in the fields of medical writing, research, and scientific analysis. Ann currently serves as the Director of Medical Writing Services at Whitsell Innovations, Inc., where they manage projects, leads teams, and specializes in writing clinical research and regulatory documents. Ann has expertise in oncology and experience in various therapeutic areas. Prior to this role, they were a Senior Writer and Manager at the same company, contributing to the writing and management of medical content. Before joining Whitsell Innovations, Ann worked as a Postdoctoral Research Associate at the University of North Carolina at Chapel Hill, focusing on cell signaling and metastasis in cancer research. Ann completed their PhD in molecular cancer biology from Duke University, where they investigated the role of methotrexate in cell signaling in oncogenesis. Additionally, they worked as a Research Associate at the University of Miami, Miller School of Medicine, conducting research on bacteriorhodopsin and contributing to grant proposals and research articles. Ann began their scientific career as a Scientist at Ciba-Geigy, managing research projects in systemic acquired resistance. Throughout their career, Ann has presented their research, trained students, and provided support for patent applications.

Ann Winter-Vann obtained a Bachelor of Science degree in Biology from Duke University in the years 1988 to 1992. Later, they pursued further education at Duke University, completing a PhD in Molecular Cancer Biology from 1998 to 2004.